Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501824 | SCV000596818 | benign | not specified | 2021-03-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000651120 | SCV000772970 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001692152 | SCV001911050 | benign | not provided | 2020-04-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438222 | SCV002748521 | likely benign | Inborn genetic diseases | 2022-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001692152 | SCV005314086 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272658 | SCV001454897 | benign | Dyskeratosis congenita | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004541569 | SCV004798904 | benign | RTEL1-related disorder | 2019-03-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |